Back to search

Article

Integrated Proteomic and Network Analysis Reveals Dysregulated Pathways and Candidate Proteins in Multiple Myeloma Progression

2026-05-24

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Multiple myeloma (MM) remains incurable despite therapeutic advances, reflecting limited understanding of the molecular mechanisms underlying disease initiation and progression. MM develops through asymptomatic precursor stages, monoclonal gammopathy of undetermined significance (MGUS) and smouldering multiple myeloma (SMM). This study aimed to investigate protein changes as...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2f209605-a4b1-5bd6-bc4c-22dca2d418c1
DOI
10.64898/2026.05.21.26353799
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrated Proteomic and Network Analysis Reveals Dysregulated Pathways and Candidate Proteins in Multiple Myeloma ProgressionDOI 10.64898/2026.05.21.26353799
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunitiesSemantic proximity
Exploring the Molecular Mechanisms and Shared Genetic Characteristics of Monoclonal Gammopathy of Undetermined Significance and Multiple MyelomaSemantic proximity
CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagySemantic proximity
Proteomics and functional study reveal marginal zone B and B1 cell specific protein as a candidate marker of multiple myelomaSemantic proximity
Serum proteomic profiling reveals MTA2 and AGO2 as novel prognostic biomarkers associated with disease activity and adverse outcomes in multiple myelomaSemantic proximity
Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profilingSemantic proximity
Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple MyelomaSemantic proximity
Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolomeSemantic proximity
Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets.Semantic proximity
Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal GammopathiesSemantic proximity
Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.Semantic proximity
Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic StrategiesSemantic proximity
Select a neighboring publication to make it the new centre.